Hansoh Pharmaceutical Group Company Limited
HKEX:3692.HK
Overview | Financials
Company Name | Hansoh Pharmaceutical Group Company Limited |
Symbol | 3692.HK |
Currency | HKD |
Price | 17.7 |
Market Cap | 105,037,728,350 |
Dividend Yield | 1.16% |
52-week-range | 11.18 - 22.8 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Huijuan Zhong |
Website | https://www.hspharm.com |
An error occurred while fetching data.
About Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, and metabolic diseases. Its principal products include Mailingda, a drug
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD